Anthracycline subcellular distribution in human leukemic cells by microspectrofluorometry: Factors contributing to drug-induced cell death and reversal of multidrug resistance

Leukemia

Volumn 11, Issue 7, 1997, Pages 1170-1179

  Morjani, H ^a   Millot, J M ^a   Belhoussine, R ^a   Sebille, S ^a   Manfait, M ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Anthracycline; Cell death; Cellular distribution; Microspectrofluorometry; Multidrug resistance; Reversal

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; ANTHRACYCLINE; CYCLOSPORIN A; DNA; DNA TOPOISOMERASE; DOXORUBICIN; GLYCOPROTEIN P; QUININE; VERAPAMIL;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE; MEMBRANE BINDING; MICROFLUOROMETRY; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE;

EID: 0030786591     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400668     Document Type: Article

References (14)

1. Tritton TR. Cell surface actions of adriamycin. Pharmac Ther 1991; 49: 293-309.
2. Jaffrezou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 1996; 15: 2417-2424.
3. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995; 82: 405-414.
4. Bennis S, lchas F, Robert J. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a leukemia cell line. Int J Cancer 1995; 62: 283-290.
5. Schuurhuis GJ, Broxterman HJ, Cervantes A, Van Heijningen THM, De Lange JHM, Baak JPA, Pinedo HM, Lankelma J. Quantitative determination of factors contributing to doxorubucin resistance in multidrug-resistant cells. J Natl Cancer Inst 1989; 81: 1887-1892.
6. Jaffrezou JP, Chen G, Duran GE, Muller C, Bordier C, Laurent G, Sikic BI, Levade T. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochem Biophys Acta 1995; 1266: 1-8.
7. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
8. Bradley G, Juranka PF, Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta 1988; 948: 87-128.
9. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 1988; 33: 454-462.
10. Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 1994; 32: 9156-9164.
11. Gill DR, Hyde SC, Higgins CF, Valverde MA, Mitenig GM, Sepulvedan FV. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 1992; 71: 23-32.
12. Sardini A, Mintenig GM, Valverde MA, Sepulvelda FV, Gill DR, Hyde SC, Higgins CF, McNaughton PA. Drug efflux mediated by the multidrug resistance P-glycoprotein is inhibited by cell swelling. J Cell Sci 1994; 107: 3281-3290.
13. Hardy SP, Goodfellow HR, Valverde MA, Gill DR, Sepulveda FV. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 1995; 14: 68-75.
14. Roepe PD. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry 1992; 31: 12555-12564.